Skip to main content
SpringerLink
Log in

Experimentelle Grundlagen zur Sekundärprophylaxe arteriosklerotischer Erkrankungen hirnversorgender Gefäße mit Calcium-Antagonisten

  • Conference paper
Calcium-Antagonisten in der Neurologie

  • 10 Accesses

Zusammenfassung

Die Empfehlungen, Calcium-Antagonisten für die Sekundärprophylaxe der Atherogenese anzuwenden, ergaben sich vor allem aus Tierexperimenten und Untersuchungen an Zellkulturen. Mit den experimentellen Methoden gelingt es zugleich, Einblicke in Mechanismen zu erhalten, welche den Prozessen zugrundeliegen, durch die die Medikamente Einfluß auf das Wachstum der Plaques haben.

Die Arbeit wurde z. T. durch das Bundesministerium für Forschung und Technologie gefördert. Förderungs.-Nr. 0318846 17

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Allen JC, Bukoski RD (1982) Current status of vascular smooth muscle subcellular calcium regulation. In: Vascular Smooth Muscle: Metabolic, Ionic, and Contractile Mechanisms ed by MF Crass, CD Barnes, 4: 99–134. Academic Press New York

    Google Scholar 

  2. Apfel H, Betz E (1985) Der elektrische Widerstand von Arterienwänden bei Atheromentwicklung. Berichtsband, 3. Deutsch-Japanischer Kongreß für Angiologie 1984, Heidelberg, herausgegeben von HJ Maurer, Demeter Verlag, Gräfelfing, angio archiv, Z, 91–93

    Google Scholar 

  3. Betz E, Hämmerle H (1984) Arterienwandproliferate and Zellkulturen als Indikatoren für Hemmstoffe der Atherogenese. Funkt Biol Med, 3: 46–55

    CAS  Google Scholar 

  4. Betz E, Hämmerle H (1986) Effect of Etofibrate and its metabolites on atheromas of rabbits and on smooth muscle cell cultures. Arzneim-Forsch/ Drug Res, 36: 92–98

    CAS  Google Scholar 

  5. Betz E, Hämmerle H, Strohschneider T (1985) Inhibition of smooth muscle cell proliferation and endothelial permeability with Flunarizine in vitro and in experimental atheromas. Res Exp Med, 185: 325–340

    Article  CAS  Google Scholar 

  6. Blumlein SL, Sievers R, Kidd P, Parmley WW (1984) Mechanism of protection from atherosclerosis by Verapamil in the cholesterol-fed rabbit. Amer J Cardiol, 54: 884–889

    Article  PubMed  CAS  Google Scholar 

  7. Charp PA, Whitson GL (1980) Calcium and cyclic nucleotide interactions during the cell cycle. In: Nuclear-Cytoplasmic Interactions in the Cell, Academic Press, 309–333

    Google Scholar 

  8. Charp PA, Whitson GL (1982) The central role of calcium in the modulation of cell division. In: Genetic Expression in the Cell Cycle. Cell Biology, ed by GM Padilla, KS McCarty, Academic Press, New York, 393–409

    Google Scholar 

  9. DeFeudis FV (1983) “Calcium-antagonists” and atherosclerosis. Basic studies and therapeutic implications. Life Sciences, 32: 557–563

    Google Scholar 

  10. Doerr W (1979) Die Entwicklung der Arteriosklerose in morphologischer Sicht. In: Gefäßwand — Rezidivprophylaxe — Raynaud-Syndrom, herausgegeben von H Ehringer, E Betz, A Bollinger and E Deutsch, Verlag Gerhard Witzstrock, Baden-Baden Köln New York, 27–38

    Google Scholar 

  11. Forssmann WG (1969) A method for in vivo diffusion tracer studies combining perfusion fixation with intravenous tracer injection. Histochemie, 20: 277–286

    Article  PubMed  CAS  Google Scholar 

  12. Glossmann H, Goll A, Rombusch M, Ferry DR (1985) Molecular pharmacology of Cat+ channels: Receptor binding studies. In: Nimodipine, Pharmacological and Clinical Properties ed by E Betz, K Deck, F Hoffmeister. FK Schattauer-Verlag, Stuttgart New York, 57–73

    Google Scholar 

  13. Harris PJ (1981) Calcium regulation of cell cycle events. In: Mitosis/ Cytokinesis, Cell Biol, ed by AM Zimmerman, A Forer, Academic Press, New York, 29–57

    Google Scholar 

  14. Kling D, Holzschuh T, Betz E (1987) Temporal sequence of morphological alterations in artery walls during experimental atherogenesis — occurrence of leukocytes. Res Exp Med, im Druck

    Google Scholar 

  15. Kramsch DM, Aspen AJ, Apstein CS (1980) Suppression of experimental atherosclerosis by the Ca“-antagonist Lanthanum. J Clin Invest, 65: 967–981

    Article  PubMed  CAS  Google Scholar 

  16. Kramsch DM, Aspen AJ, Rozier U (1981) Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids. Science, 213: 1511–1512

    Article  PubMed  CAS  Google Scholar 

  17. Kramsch DM, Chan CT (1978) The effect of agents interfering with soft tissue calcification and cell proliferation of calcific fibrous-fatty plaques in rabbits. Circulat Res, 42: 562–571

    PubMed  CAS  Google Scholar 

  18. Kramsch DM, Chan CT, Aspen AJ, Wells H (1978) Prevention and therapy of induced atherosclerosis in rabbits and monkeys. In: State of Prevention and Therapy in Human Arteriosclerosis and in Animal Models ed by WH Hauss, RW Wissler, R Lehmann, Rhein-Westfäl Akad Wiss, Abh Bd 63, Westdeutscher Verlag Opladen, 153–172

    Google Scholar 

  19. Long WF, Williamson FB (1979) Glycosaminoglycans, calcium ions and the control of cell proliferation. IRCS Med Sci, Z, 429–434

    Google Scholar 

  20. Nakao J, Ito H, Ooyama T, Chang WC, Murota SI (1983) Calcium dependency of aortic smooth muscle cell migration induced by 12-L-Hydroxy-5, 8, 10, 14-eicosatetraenoic acid. Effects of A23187, Nicardipine and Trifluoperazine. Atherosclerosis, 46: 309–319

    CAS  Google Scholar 

  21. Roth J, Betz E, Schlote W (1980) Einfluß von 2-Äthyl-3-(4-hydroxybenzoyl)-benzofuran (Benzaron) auf die experimentell erzeugte Atheromatose. Arzneim-Forsch/Drug Res, 30: 1897–1902

    CAS  Google Scholar 

  22. Rouleau JL, Parmley WW, Stevens J, Wikman-Coffelt J, Sievers R, Mah-ley RW, Havel RJ, Brecht W (1983) Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Amer Coll Cardiol, 1: 1453–1460

    Article  CAS  Google Scholar 

  23. Stoclet JC, Lugnier C, Follenius A, Scheftel JM, Gerard D (1985) Calmodulin and calcium regulation: Effect of antagonists. In: Calcium Entry Blockers and Tissue Protection ed by T Godfraind, PM Vanhoutte, S Govoni, R Paoletti, Raven Press, New York, 31–40

    Google Scholar 

  24. Weiss GB (1985) Calcium antagonists as antiatherosclerotic drugs. Drug Development Research, 6: 135–139

    Article  Google Scholar 

Download references

Authors
  1. E. Betz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Neurologie, Westf. Wilhelms-Universität Münster, Albert-Schweitzer-Straße 33, 4400, Münster, Deutschland

    Bernhard Hofferberth  & Günther G. Brune  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Betz, E. (1988). Experimentelle Grundlagen zur Sekundärprophylaxe arteriosklerotischer Erkrankungen hirnversorgender Gefäße mit Calcium-Antagonisten. In: Hofferberth, B., Brune, G.G. (eds) Calcium-Antagonisten in der Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73300-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73300-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18723-3

  • Online ISBN: 978-3-642-73300-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation